The Alexander Project 1999: S. pneumoniae, Macrolide Resistance
Brazil 4.0%
Mexico
22%
USA 33%
South Africa
13%
Saudi Arabia 18%
Hong Kong 82%
Israel 23%
Japan 78%
Singapore 55%
Kenya
0.5%
Russia 7%
Europe 20%
Resistance defined as erythromycin MIC ³1mg/L
Previous slide
Next slide
Back to first slide
View graphic version